https://orcid.org/0000-0001-6451-7349
References
- Szarewski A, Moeller C. Women’s perceptions about reducing the frequency of monthly bleeding: results from a multinational survey. Open Access J Contraception. 2013;4:29–37.
- Ferrero S, Abbamonte LH, Giordano M, et al. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception. 2006;73:537–541.
- Szarewski A, von Stenglin A, Rybowski S. Women’s attitudes towards monthly bleeding: results of a global population-based survey. Eur J Contracept Reprod Health Care. 2012;17:270–283.
- Aubeny E. Are monthly menstrual periods optional? A European perspective. Reprod Health Matters. 2007;15:183–185.
- Loudon NB, Foxwell M, Potts DM, et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br Med J. 1977;2:487–490.
- Merki-Feld GS, Breitschmid N, Seifert B, et al. A survey on Swiss women’s preferred menstrual/withdrawal bleeding pattern over different phases of reproductive life and with use of hormonal contraception. Eur J Contracept Reprod Health Care. 2014;19:266–275.
- Edelman A, Micks E, Gallo MF, et al. Continuous or extended cycle vs cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;7:CD004695.
- Pincus G. The control of fertility. New York: Academic Press; 1965.
- Nappi RE, Fiala C, Chabbert-Buffet N, et al. Women’s preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey. Eur J Contracept Reprod Health Care. 2016;21:242–250.
- Kaunitz AM, Dean CL. Counseling our patients regarding cycle control - highlights from a randomized clinical trial comparing a 21-day and a 24-day oral contraceptive regimen. OBG Manag. 2010;22:S3–S9.
- Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception. 2007;75:16–22.
- Mansour D, Verhoeven C, Sommer W, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reprod Health Care. 2011;16:430–443.
- Wiegratz I, Hommel HH, Zimmermann T, et al. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69:37–42.
- Fruzzetti F, Paoletti AM, Lombardo M, et al. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Eur J Contracept Reprod Health Care. 2008;13:153–157.
- Gunson JS. ‘More natural but less normal’: reconsidering medicalisation and agency through women’s accounts of menstrual suppression. Soc Sci Med. 2010;71:1324–1331.
- Repta R, Hurd Clarke L. ‘Am I going to be natural or am I not?’ Canadian women’s perceptions and experiences of menstrual suppression. Sex Roles. 2013;68:91–106.
- Chrisler JC, Marván ML, Gorman JA, et al. Body appreciation and attitudes toward menstruation. Body Image. 2015;12:78–81.
- Johnston-Robledo I, Ball M, Lauta K, et al. To bleed or not to bleed: young women’s attitudes toward menstrual suppression. Women Health. 2003;38:59–75.
- Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet. 2000;355:922–924.
- Blanchard K. Life without menstruation. Obstet Gynaecol. 2003;5:34–37.
- Brantelid IE, Nilvér H, Alehagen S. Menstruation during a lifespan: a qualitative study of women’s experiences. Health Care Women Int. 2014;35:600–616.